Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Research article

Productivity costs from a dengue episode in Asia: a systematic literature review

Authors: Trinh Manh Hung, Donald S. Shepard, Alison A. Bettis, Huyen Anh Nguyen, Angela McBride, Hannah E. Clapham, Hugo C. Turner

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Dengue is a mosquito-borne viral infection which has been estimated to cause a global economic burden of US$8.9 billion per year. 40% of this estimate was due to what are known as productivity costs (the costs associated with productivity loss from both paid and unpaid work that results from illness, treatment or premature death). Although productivity costs account for a significant proportion of the estimated economic burden of dengue, the methods used to calculate them are often very variable within health economic studies. The aim of this review was to systematically examine the current estimates of the productivity costs associated with dengue episodes in Asia and to increase awareness surrounding how productivity costs are estimated.

Method

We searched PubMed and Web of Knowledge without date and language restrictions using terms related to dengue and cost and economics burden. The titles and abstracts of publications related to Asia were screened to identify relevant studies. The reported productivity losses and costs of non-fatal and fatal dengue episodes were then described and compared. Costs were adjusted for inflation to 2017 prices.

Results

We reviewed 33 relevant articles, of which 20 studies reported the productivity losses, and 31 studies reported productivity costs. The productivity costs varied between US$6.7–1445.9 and US$3.8–1332 for hospitalized and outpatient non-fatal episodes, respectively. The productivity cost associated with fatal dengue episodes varied between US$12,035-1,453,237. A large degree of this variation was due to the range of different countries being investigated and their corresponding economic status. However, estimates for a given country still showed notable variation.

Conclusion

We found that the estimated productivity costs associated with dengue episodes in Asia are notable. However, owing to the significant variation in methodology and approaches applied, the reported productivity costs of dengue episodes were often not directly comparable across studies. More consistent and transparent methodology regarding the estimation of productivity costs would help the estimates of the economic burden of dengue be more accurate and comparable across studies.
Appendix
Available only for authorised users
Literature
2.
go back to reference Murray CJ, Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–544.CrossRef Murray CJ, Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–544.CrossRef
3.
go back to reference Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al. The global burden of dengue: an analysis from the global burden of disease study 2013. Lancet Infect Dis. 2016;16:712–23.PubMedPubMedCentralCrossRef Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al. The global burden of dengue: an analysis from the global burden of disease study 2013. Lancet Infect Dis. 2016;16:712–23.PubMedPubMedCentralCrossRef
4.
go back to reference Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: a systematic analysis. Lancet Infect Dis. 2016;16:935–41.PubMedCrossRef Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: a systematic analysis. Lancet Infect Dis. 2016;16:935–41.PubMedCrossRef
5.
go back to reference Koopmanschap MA, van Ineveld BM. Towards a new approach for estimating indirect costs of disease. Soc Sci Med. 1992;34(9):1005–10.PubMedCrossRef Koopmanschap MA, van Ineveld BM. Towards a new approach for estimating indirect costs of disease. Soc Sci Med. 1992;34(9):1005–10.PubMedCrossRef
6.
go back to reference Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Econ. 1997;6(5):511–4.PubMedCrossRef Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Econ. 1997;6(5):511–4.PubMedCrossRef
7.
go back to reference Krol M, Brouwer W, Rutten F. Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics. 2013;31:537–49.PubMedCrossRef Krol M, Brouwer W, Rutten F. Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics. 2013;31:537–49.PubMedCrossRef
11.
go back to reference Turner HC, Lauer JA, Tran BX, Teerawattananon Y, Jit M. Adjusting for Inflation and Currency Changes Within Health Economic Studies. Value Health. 2019;22(9):1026-32. Turner HC, Lauer JA, Tran BX, Teerawattananon Y, Jit M. Adjusting for Inflation and Currency Changes Within Health Economic Studies. Value Health. 2019;22(9):1026-32.
12.
go back to reference Clark DV, Mammen MP Jr, Nisalak A, Puthimethee V, Endy TP. Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels. Am J Trop Med Hyg. 2005;72(6):786–91.PubMedCrossRef Clark DV, Mammen MP Jr, Nisalak A, Puthimethee V, Endy TP. Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels. Am J Trop Med Hyg. 2005;72(6):786–91.PubMedCrossRef
13.
go back to reference Huy R, Wichmann O, Beatty M, Ngan C, Duong S, Margolis HS, et al. Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study. BMC Public Health. 2009;9:155.PubMedPubMedCentralCrossRef Huy R, Wichmann O, Beatty M, Ngan C, Duong S, Margolis HS, et al. Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study. BMC Public Health. 2009;9:155.PubMedPubMedCentralCrossRef
14.
go back to reference Mia MS, Begum RA, Er AC, Pereira JJ. Assessing the cost burden of dengue infection to households in Seremban, Malaysia. Southeast Asian J Trop Med Public Health. 2016;47(6):1167–76.PubMed Mia MS, Begum RA, Er AC, Pereira JJ. Assessing the cost burden of dengue infection to households in Seremban, Malaysia. Southeast Asian J Trop Med Public Health. 2016;47(6):1167–76.PubMed
15.
go back to reference Okanurak K, Sornmani S, Indaratna K. The cost of dengue hemorrhagic fever in Thailand. Southeast Asian J Trop Med Public Health. 1997;28(4):711–7.PubMed Okanurak K, Sornmani S, Indaratna K. The cost of dengue hemorrhagic fever in Thailand. Southeast Asian J Trop Med Public Health. 1997;28(4):711–7.PubMed
16.
go back to reference Suaya JA, Shepard DS, Siqueira JB, Martelli CT, Lum LC, Tan LH, et al. Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. Am J Trop Med Hyg. 2009;80(5):846–55.PubMedCrossRef Suaya JA, Shepard DS, Siqueira JB, Martelli CT, Lum LC, Tan LH, et al. Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. Am J Trop Med Hyg. 2009;80(5):846–55.PubMedCrossRef
17.
go back to reference Kongsin S, Jiamton S, Suaya JA, Vasanawathana S, Sirisuvan P, Shepard DS. Cost of dengue in Thailand. Dengue Bull. 2010;34:77–88. Kongsin S, Jiamton S, Suaya JA, Vasanawathana S, Sirisuvan P, Shepard DS. Cost of dengue in Thailand. Dengue Bull. 2010;34:77–88.
18.
go back to reference Suaya JA, Chantha N, Huy R, Sah BK, Moh-Seng C, Socheat D, et al. Clinical characterization, diagnosis and socioeconomic impact of hospitalized dengue in Cambodia. Dengue Bull. 2010;34:89–102. Suaya JA, Chantha N, Huy R, Sah BK, Moh-Seng C, Socheat D, et al. Clinical characterization, diagnosis and socioeconomic impact of hospitalized dengue in Cambodia. Dengue Bull. 2010;34:89–102.
19.
go back to reference Onuh W, Cabanacan-Salibay C, Manaig P. Economic costs and burden of dengue disease in Cavite Province, Philippines. Sci Med. 2016;26(2):11.CrossRef Onuh W, Cabanacan-Salibay C, Manaig P. Economic costs and burden of dengue disease in Cavite Province, Philippines. Sci Med. 2016;26(2):11.CrossRef
20.
go back to reference Tam PT, Dat NT, Huu LM, Thi XCP, Duc HM, Tu TC, et al. High household economic burden caused by hospitalization of patients with severe dengue fever cases in Can Tho province, Vietnam. Am J Trop Med Hyg. 2012;87(3):554–8.PubMedPubMedCentralCrossRef Tam PT, Dat NT, Huu LM, Thi XCP, Duc HM, Tu TC, et al. High household economic burden caused by hospitalization of patients with severe dengue fever cases in Can Tho province, Vietnam. Am J Trop Med Hyg. 2012;87(3):554–8.PubMedPubMedCentralCrossRef
21.
go back to reference Pham LD, Tran NHP, Le NDT, Vo TQ. Economic report on the cost of dengue fever in Vietnam: case of a provincial hospital. Clinicoecon Outcomes Res. 2016;9:1–8.PubMedPubMedCentralCrossRef Pham LD, Tran NHP, Le NDT, Vo TQ. Economic report on the cost of dengue fever in Vietnam: case of a provincial hospital. Clinicoecon Outcomes Res. 2016;9:1–8.PubMedPubMedCentralCrossRef
22.
go back to reference Nguyen TKT, Luong CQ. Assessing the economic burden of dengue in southern Viet Nam: results of a prospective multicenter cost study; 2011. Nguyen TKT, Luong CQ. Assessing the economic burden of dengue in southern Viet Nam: results of a prospective multicenter cost study; 2011.
23.
go back to reference Suaya JA, Shepard DS, Chang MS, Caram M, Hoyer S, Socheat D, et al. Cost-effectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti. Tropical Med Int Health. 2007;12(9):1026–36.CrossRef Suaya JA, Shepard DS, Chang MS, Caram M, Hoyer S, Socheat D, et al. Cost-effectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti. Tropical Med Int Health. 2007;12(9):1026–36.CrossRef
24.
go back to reference Harving ML, Rönsholt FF. The economic impact of dengue hemorrhagic fever on family level in southern Vietnam. Dan Med Bull. 2007;54(2):170–2.PubMed Harving ML, Rönsholt FF. The economic impact of dengue hemorrhagic fever on family level in southern Vietnam. Dan Med Bull. 2007;54(2):170–2.PubMed
25.
go back to reference Shepard DS, Undurraga EA, Lees RS, Halasa Y, Lum LC, Ng CW. Use of multiple data sources to estimate the economic cost of dengue illness in Malaysia. Am J Trop Med Hyg. 2012;87(5):796–805.PubMedPubMedCentralCrossRef Shepard DS, Undurraga EA, Lees RS, Halasa Y, Lum LC, Ng CW. Use of multiple data sources to estimate the economic cost of dengue illness in Malaysia. Am J Trop Med Hyg. 2012;87(5):796–805.PubMedPubMedCentralCrossRef
26.
go back to reference Lee JS, Mogasale V, Lim JK, Carabali M, Lee KS, Sirivichayakul C, et al. A multi-country study of the economic burden of dengue fever: Vietnam, Thailand, and Colombia. PLoS Negl Trop Dis. 2017;11(10):e0006037.PubMedPubMedCentralCrossRef Lee JS, Mogasale V, Lim JK, Carabali M, Lee KS, Sirivichayakul C, et al. A multi-country study of the economic burden of dengue fever: Vietnam, Thailand, and Colombia. PLoS Negl Trop Dis. 2017;11(10):e0006037.PubMedPubMedCentralCrossRef
27.
go back to reference Bhavsar AT, Shepard DS, Suaya JA, Mafowosofo M, Hurley CL. A private hospital-based study assessing knowledge, attitudes, practices and costs associated with dengue illness in Surat. India Dengue Bull. 2010;34:54–64. Bhavsar AT, Shepard DS, Suaya JA, Mafowosofo M, Hurley CL. A private hospital-based study assessing knowledge, attitudes, practices and costs associated with dengue illness in Surat. India Dengue Bull. 2010;34:54–64.
28.
go back to reference Tran NYN, Vo QT. The economic value of informal care for dengue patients in Vietnam. Int J Res Ayurveda Pharm. 2016;7(6):101–6. Tran NYN, Vo QT. The economic value of informal care for dengue patients in Vietnam. Int J Res Ayurveda Pharm. 2016;7(6):101–6.
29.
go back to reference Tozan Y, Ratanawong P, Sewe MO, Wilder-Smith A, Kittayapong P. Household costs of hospitalized dengue illness in semi-rural Thailand. PLoS Negl Trop Dis. 2017;11(9):e0005961.PubMedPubMedCentralCrossRef Tozan Y, Ratanawong P, Sewe MO, Wilder-Smith A, Kittayapong P. Household costs of hospitalized dengue illness in semi-rural Thailand. PLoS Negl Trop Dis. 2017;11(9):e0005961.PubMedPubMedCentralCrossRef
30.
go back to reference Tran BX, Thu GV, Hoang LN, Tuan ALN, Thanh TT, Thanh BN, et al. Cost-of-Illness and the Health-Related Quality of Life of Patients in the Dengue Fever Outbreak in Hanoi in 2017. Int J Environ Res Public Health. 2018;15(6):1174. Tran BX, Thu GV, Hoang LN, Tuan ALN, Thanh TT, Thanh BN, et al. Cost-of-Illness and the Health-Related Quality of Life of Patients in the Dengue Fever Outbreak in Hanoi in 2017. Int J Environ Res Public Health. 2018;15(6):1174.
31.
go back to reference El Fezzazi H, Branchu M, Carrasquilla G, Pitisuttithum P, Perroud AP, Frago C, et al. Resource use and costs of dengue: analysis of data from phase III efficacy studies of a tetravalent dengue vaccine. Am J Trop Med Hyg. 2017;97(6):1898–903.PubMedPubMedCentralCrossRef El Fezzazi H, Branchu M, Carrasquilla G, Pitisuttithum P, Perroud AP, Frago C, et al. Resource use and costs of dengue: analysis of data from phase III efficacy studies of a tetravalent dengue vaccine. Am J Trop Med Hyg. 2017;97(6):1898–903.PubMedPubMedCentralCrossRef
32.
go back to reference Zeng W, Halasa-Rappel YA, Baurin N, Coudeville L, Shepard DS. Cost-effectiveness of dengue vaccination in ten endemic countries. Vaccine. 2018;36(3):413–20.PubMedCrossRef Zeng W, Halasa-Rappel YA, Baurin N, Coudeville L, Shepard DS. Cost-effectiveness of dengue vaccination in ten endemic countries. Vaccine. 2018;36(3):413–20.PubMedCrossRef
34.
go back to reference Nadjib M, Setiawan E, Putri S, Nealon J, Beucher S, Hadinegoro SR, et al. Economic burden of dengue in Indonesia. PLoS Negl Trop Dis. 2019;13(1):e0007038.PubMedPubMedCentralCrossRef Nadjib M, Setiawan E, Putri S, Nealon J, Beucher S, Hadinegoro SR, et al. Economic burden of dengue in Indonesia. PLoS Negl Trop Dis. 2019;13(1):e0007038.PubMedPubMedCentralCrossRef
35.
go back to reference Lee J-S, Mogasale V, Lim JK, Ly S, Lee KS, Sorn S, et al. A multi-country study of the economic burden of dengue fever based on patient-specific field surveys in Burkina Faso, Kenya, and Cambodia. PLoS Negl Trop Dis. 2019;13(2):e0007164.PubMedPubMedCentralCrossRef Lee J-S, Mogasale V, Lim JK, Ly S, Lee KS, Sorn S, et al. A multi-country study of the economic burden of dengue fever based on patient-specific field surveys in Burkina Faso, Kenya, and Cambodia. PLoS Negl Trop Dis. 2019;13(2):e0007164.PubMedPubMedCentralCrossRef
36.
go back to reference Bangert M, Latheef AT, Pant SD, Ahmed IN, Saleem S, Rafeeq FN, et al. Economic analysis of dengue prevention and case management in the Maldives. PLoS Negl Trop Dis. 2018;12(9):e0006796.PubMedPubMedCentralCrossRef Bangert M, Latheef AT, Pant SD, Ahmed IN, Saleem S, Rafeeq FN, et al. Economic analysis of dengue prevention and case management in the Maldives. PLoS Negl Trop Dis. 2018;12(9):e0006796.PubMedPubMedCentralCrossRef
37.
go back to reference Carrasco LR, Lee LK, Lee VJ, Ooi EE, Shepard DS, Thein TL, et al. Economic impact of dengue illness and the cost-effectiveness of future vaccination programs in Singapore. PLoS Negl Trop Dis. 2011;5(12):e1426.PubMedPubMedCentralCrossRef Carrasco LR, Lee LK, Lee VJ, Ooi EE, Shepard DS, Thein TL, et al. Economic impact of dengue illness and the cost-effectiveness of future vaccination programs in Singapore. PLoS Negl Trop Dis. 2011;5(12):e1426.PubMedPubMedCentralCrossRef
38.
go back to reference Hariharan D, Das MK, Shepard DS, Arora NK. Economic burden of dengue illness in India from 2013 to 2016: A systematic analysis. Int J Infect Dis. 2019;84:S68-73. Hariharan D, Das MK, Shepard DS, Arora NK. Economic burden of dengue illness in India from 2013 to 2016: A systematic analysis. Int J Infect Dis. 2019;84:S68-73.
41.
go back to reference Luh DL, Liu CC, Luo YR, Chen SC. Economic cost and burden of dengue during epidemics and non-epidemic years in Taiwan. J Infect Public Health. 2017;11(2):215-23. Luh DL, Liu CC, Luo YR, Chen SC. Economic cost and burden of dengue during epidemics and non-epidemic years in Taiwan. J Infect Public Health. 2017;11(2):215-23.
42.
go back to reference Anderson KB, Chunsuttiwat S, Nisalak A, Mammen MP, Libraty DH, Rothman AL, et al. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet. 2007;369(9571):1452–9.PubMedCrossRef Anderson KB, Chunsuttiwat S, Nisalak A, Mammen MP, Libraty DH, Rothman AL, et al. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet. 2007;369(9571):1452–9.PubMedCrossRef
43.
go back to reference Li X, Gignac MA, Anis AH. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work. Med Care. 2006;44(4):304–10.PubMedCrossRef Li X, Gignac MA, Anis AH. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work. Med Care. 2006;44(4):304–10.PubMedCrossRef
44.
go back to reference Burton WN, Chen C-Y, Conti DJ, Schultz AB, Pransky G, Edington DW. The association of health risks with on-the-job productivity. J Occup Environ Med. 2005;47(8):769–77.PubMedCrossRef Burton WN, Chen C-Y, Conti DJ, Schultz AB, Pransky G, Edington DW. The association of health risks with on-the-job productivity. J Occup Environ Med. 2005;47(8):769–77.PubMedCrossRef
45.
go back to reference Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting US employers. J Occup Environ Med. 2004;46(4):398–412.PubMedCrossRef Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting US employers. J Occup Environ Med. 2004;46(4):398–412.PubMedCrossRef
46.
go back to reference Rafique I, Nadeem Saqib MA, Munir MA, Qureshi H, Siddiqui S, Habibullah S, et al. Economic burden of dengue in four major cities of Pakistan during 2011. J Pak Med Assoc. 2015;65(3):256–9.PubMed Rafique I, Nadeem Saqib MA, Munir MA, Qureshi H, Siddiqui S, Habibullah S, et al. Economic burden of dengue in four major cities of Pakistan during 2011. J Pak Med Assoc. 2015;65(3):256–9.PubMed
47.
go back to reference Seet RC, Quek AM, Lim EC. Post-infectious fatigue syndrome in dengue infection. J Clin Virol. 2007;38(1):1–6.PubMedCrossRef Seet RC, Quek AM, Lim EC. Post-infectious fatigue syndrome in dengue infection. J Clin Virol. 2007;38(1):1–6.PubMedCrossRef
48.
go back to reference Tiga DC, Undurraga EA, Ramos-Castañeda J, Martínez-Vega RA, Tschampl CA, Shepard DS. Persistent symptoms of dengue: estimates of the incremental disease and economic burden in Mexico. Am J Trop Med Hyg. 2016;94(5):1085–98.PubMedPubMedCentralCrossRef Tiga DC, Undurraga EA, Ramos-Castañeda J, Martínez-Vega RA, Tschampl CA, Shepard DS. Persistent symptoms of dengue: estimates of the incremental disease and economic burden in Mexico. Am J Trop Med Hyg. 2016;94(5):1085–98.PubMedPubMedCentralCrossRef
49.
go back to reference Hung TM, Wills B, Clapham HE, Yacoub S, Turner HC. The uncertainty surrounding the burden of post-acute consequences of dengue infection. Trends Parasitol. 2019;35(9):673–6.PubMedCrossRef Hung TM, Wills B, Clapham HE, Yacoub S, Turner HC. The uncertainty surrounding the burden of post-acute consequences of dengue infection. Trends Parasitol. 2019;35(9):673–6.PubMedCrossRef
57.
go back to reference Varkkey B, Korde R, Singh S. minimum Wage Comparison: Asian Countries – Minimum Wage Fixing; 2016. Varkkey B, Korde R, Singh S. minimum Wage Comparison: Asian Countries – Minimum Wage Fixing; 2016.
62.
go back to reference Teixeira MG, Barreto ML, Costa MCN, Ferreira LDA, Vasconcelos PF, Cairncross S. Dynamics of dengue virus circulation: a silent epidemic in a complex urban area. Tropical Med Int Health. 2002;7(9):757–62.CrossRef Teixeira MG, Barreto ML, Costa MCN, Ferreira LDA, Vasconcelos PF, Cairncross S. Dynamics of dengue virus circulation: a silent epidemic in a complex urban area. Tropical Med Int Health. 2002;7(9):757–62.CrossRef
63.
go back to reference Koopmanschap MA, Rutten FF, van Ineveld BM, Van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995;14(2):171–89.PubMedCrossRef Koopmanschap MA, Rutten FF, van Ineveld BM, Van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995;14(2):171–89.PubMedCrossRef
64.
go back to reference Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG. Cost-effectiveness in health and medicine, Second edn. New York: Oxford University Press; 2016. Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG. Cost-effectiveness in health and medicine, Second edn. New York: Oxford University Press; 2016.
65.
go back to reference Verbooy K, Hoefman R, van Exel J, Brouwer W. Time is money: investigating the value of leisure time and unpaid work. Value Health. 2018;21(12):1428–36.PubMedCrossRef Verbooy K, Hoefman R, van Exel J, Brouwer W. Time is money: investigating the value of leisure time and unpaid work. Value Health. 2018;21(12):1428–36.PubMedCrossRef
66.
go back to reference Castro MC, Wilson ME, Bloom DE. Disease and economic burdens of dengue. Lancet Infect Dis. 2017;17(3):e70–e8.PubMedCrossRef Castro MC, Wilson ME, Bloom DE. Disease and economic burdens of dengue. Lancet Infect Dis. 2017;17(3):e70–e8.PubMedCrossRef
67.
go back to reference Andronis L, Maredza M, Petrou S. Measuring, valuing and including forgone childhood education and leisure time costs in economic evaluation: methods, challenges and the way forward. Soc Sci Med. 2019;237:112475.PubMedCrossRef Andronis L, Maredza M, Petrou S. Measuring, valuing and including forgone childhood education and leisure time costs in economic evaluation: methods, challenges and the way forward. Soc Sci Med. 2019;237:112475.PubMedCrossRef
68.
go back to reference Nyman JA. Cost recommendations in the second edition of cost-effectiveness in health and medicine: a review. MDM Policy Pract. 2018;3(1):1–6. Nyman JA. Cost recommendations in the second edition of cost-effectiveness in health and medicine: a review. MDM Policy Pract. 2018;3(1):1–6.
69.
go back to reference Lakdawalla DN, Doshi JA, Garrison LP, Phelps CE, Basu A, Danzon PM. Defining elements of value in health care—a health economics approach: an ISPOR special task force report [3]. Value Health. 2018;21(2):131–9.PubMedCrossRef Lakdawalla DN, Doshi JA, Garrison LP, Phelps CE, Basu A, Danzon PM. Defining elements of value in health care—a health economics approach: an ISPOR special task force report [3]. Value Health. 2018;21(2):131–9.PubMedCrossRef
70.
go back to reference Gardner JW, Sanborn JS. Years of potential life lost (YPLL)—what does it measure? Epidemiology. 1990;1:322–9.PubMedCrossRef Gardner JW, Sanborn JS. Years of potential life lost (YPLL)—what does it measure? Epidemiology. 1990;1:322–9.PubMedCrossRef
71.
go back to reference World Health Organization. Making choice in health: WHO guide to cost effective analysis. Geneva: WHO; 2003. World Health Organization. Making choice in health: WHO guide to cost effective analysis. Geneva: WHO; 2003.
73.
go back to reference Hung TM, Clapham HE, Bettis AA, Cuong HQ, Thwaites GE, Wills BA, et al. The estimates of the health and economic burden of dengue in Vietnam. Trends Parasitol. 2018;34(10):904–18.PubMedPubMedCentralCrossRef Hung TM, Clapham HE, Bettis AA, Cuong HQ, Thwaites GE, Wills BA, et al. The estimates of the health and economic burden of dengue in Vietnam. Trends Parasitol. 2018;34(10):904–18.PubMedPubMedCentralCrossRef
74.
go back to reference Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
75.
go back to reference Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs measurement through quality of life? A response to the recommendation of the Washington panel. Health Econ. 1997;6(3):253–9.PubMedCrossRef Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs measurement through quality of life? A response to the recommendation of the Washington panel. Health Econ. 1997;6(3):253–9.PubMedCrossRef
76.
go back to reference Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes, 4th edn. New York: Oxford University Press; 2015. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes, 4th edn. New York: Oxford University Press; 2015.
77.
go back to reference Sculpher M. The role and estimation of productivity costs in economic evaluation. In: Economic evaluation in health care: Merging theory with practice. edn. Edited by Michael MD, Alistair McGuire. New York: Oxford University Press; 2001. p. 94-112. Sculpher M. The role and estimation of productivity costs in economic evaluation. In: Economic evaluation in health care: Merging theory with practice. edn. Edited by Michael MD, Alistair McGuire. New York: Oxford University Press; 2001. p. 94-112.
78.
go back to reference Olsen JA, Richardson J. Production gains from health care: what should be included in cost-effectiveness analyses? Soc Sci Med. 1999;49(1):17–26.PubMedCrossRef Olsen JA, Richardson J. Production gains from health care: what should be included in cost-effectiveness analyses? Soc Sci Med. 1999;49(1):17–26.PubMedCrossRef
79.
go back to reference Liljas B. How to calculate indirect costs in economic evaluations. Pharmacoeconomics. 1998;13(1):1–7.PubMedCrossRef Liljas B. How to calculate indirect costs in economic evaluations. Pharmacoeconomics. 1998;13(1):1–7.PubMedCrossRef
Metadata
Title
Productivity costs from a dengue episode in Asia: a systematic literature review
Authors
Trinh Manh Hung
Donald S. Shepard
Alison A. Bettis
Huyen Anh Nguyen
Angela McBride
Hannah E. Clapham
Hugo C. Turner
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05109-0

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue